Surge in Ebola Virus Cases: Raises Fresh Alarms in East Africa

Kampala, Uganda – In early 2025, Uganda faced a sobering reminder of the threat posed by one of the world’s deadliest viruses: Ebola. After more than a year of relative calm, the country reported a fresh outbreak of the Sudan strain of Ebola virus (SUDV)—a variant for which no licensed vaccine or treatment currently exists. The outbreak, which officially began on January 30, 2025, has brought renewed attention to the region’s vulnerability to viral hemorrhagic fevers and the importance of rapid, coordinated responses.

A Deadly Resurgence

The outbreak was first confirmed after the death of a nurse in Kampala, Uganda’s densely populated capital. Within days, additional cases were identified across multiple districts including Mbale, Wakiso, and Ntoroko. By mid-March, health officials confirmed a total of 14 Ebola cases—12 laboratory-confirmed and 2 probable—with 4 deaths, reflecting a case fatality rate of approximately 29%.

What initially appeared to be a limited cluster expanded into multiple regions. A particularly troubling development was the discovery of a second cluster in March, involving a 4-year-old child who later died, and several family members who tested positive. This indicated previously undetected chains of transmission, raising concerns about how far the virus might have silently spread.

Understanding the Sudan Strain

The Sudan strain of Ebola virus is genetically and clinically distinct from the Zaire strain, which has been responsible for most outbreaks in recent years. Crucially, no licensed vaccines or approved treatments currently exist for the Sudan strain, though several candidates are in development.

Historically, Sudan strain outbreaks have exhibited fatality rates between 41% and 70%, though Uganda’s recent outbreak saw a lower mortality rate, likely due to improved medical response, early case detection, and supportive care.

Rapid Government Response

Uganda’s Ministry of Health moved swiftly to contain the outbreak. Within days, a national emergency medical team was deployed, supported by the World Health Organization (WHO) and international partners. The country ramped up efforts in contact tracing, isolation, public communication, and infection prevention.

By early March, over 530 contacts were under surveillance. Hospitals set up specialized treatment units, and health workers received additional protective gear and training.

In a groundbreaking move, the government—with WHO’s backing—initiated the first-ever ring-vaccination trial for the Sudan strain, using an experimental vaccine developed by IAVI. Around 2,160 doses were deployed for high-risk contacts. Though the vaccine’s efficacy is still under evaluation, the rapid rollout marked a public health milestone, showing how science and swift action can work in tandem even during active outbreaks.

Public Awareness and Misinformation

As with previous outbreaks, misinformation posed a serious threat to containment efforts. Uganda implemented a strong community engagement strategy involving behavioral scientists, religious leaders, and local radio campaigns to inform the public and reduce stigma.

“We had to act quickly not just medically, but socially,” said Dr. Jane Aceng, Uganda’s Minister of Health. “Trust is as vital as vaccines in stopping a virus like Ebola.”

Regional Concerns

The outbreak in Uganda was not isolated. Around the same time, suspected Ebola cases were reported in the Democratic Republic of Congo (DRC), and Marburg virus outbreaks—a close viral relative—emerged in Tanzania and Rwanda. These concurrent epidemics have placed considerable strain on regional surveillance systems and prompted increased cross-border monitoring.

Outbreak Contained—For Now

On April 26, 2025, Uganda declared the outbreak officially over after 42 days without a new case—the standard threshold for containment. The announcement followed the full recovery of all known cases and the successful completion of quarantine protocols for hundreds of contacts.

A subsequent After-Action Review, conducted in June, praised Uganda’s rapid mobilization, early detection, and global collaboration. The review identified key strengths, including: